Bortezomib, Cyclophosphamide, and Dexamethasone in Treating Patients With Primary Systemic Light Chain Amyloidosis
NCT01072773
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
2
Enrollment
OTHER
Sponsor class
Conditions
Primary Systemic Amyloidosis
Interventions
DRUG:
bortezomib
DRUG:
cyclophosphamide
DRUG:
dexamethasone
Sponsor
Mayo Clinic